Galafold

Galafold · pharmadog

Patent cliff

source: FDA Orange Book

first barrier falls

May 16, 2027

313 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (62)

Jan 11, 2042method-of-use (U-2371)US 11833164
Mar 25, 2039method-of-use (U-2371)US 11633388
Mar 17, 2039compositionUS 11622962
Feb 20, 2039method-of-use (U-2371)US 11642334
Feb 16, 2039compositionUS 11826360
Feb 6, 2039method-of-use (U-2371)US 11357784
Aug 17, 2038compositionUS 11903938
May 30, 2038method-of-use (U-2371)US 10251873
May 30, 2038method-of-use (U-2371)US 10471053
May 30, 2038method-of-use (U-2371)US 10792278
May 30, 2038method-of-use (U-2371)US 10792279
May 30, 2038method-of-use (U-2371)US 10799491
May 30, 2038method-of-use (U-2371)US 10806727
May 30, 2038method-of-use (U-2371)US 10849889
May 30, 2038method-of-use (U-2371)US 10849890
May 30, 2038method-of-use (U-2371)US 10857141
May 30, 2038method-of-use (U-2371)US 10857142
May 30, 2038method-of-use (U-2371)US 10874655
May 30, 2038method-of-use (U-2371)US 10874656
May 30, 2038method-of-use (U-2371)US 10874657
May 30, 2038method-of-use (U-2371)US 11278536
May 30, 2038method-of-use (U-2371)US 11278537
May 30, 2038method-of-use (U-2371)US 11278538
May 30, 2038method-of-use (U-2371)US 11278539
May 30, 2038method-of-use (U-2371)US 11278540
May 30, 2038compositionUS 11304940
May 30, 2038method-of-use (U-2371)US 11357761
May 30, 2038method-of-use (U-2371)US 11357762
May 30, 2038method-of-use (U-2371)US 11357763
May 30, 2038compositionUS 11357764
May 30, 2038compositionUS 11357765
May 30, 2038compositionUS 11376244
May 30, 2038method-of-use (U-2371)US 11389436
May 30, 2038method-of-use (U-2371)US 11389437
May 30, 2038compositionUS 11426396
May 30, 2038method-of-use (U-2371)US 11458128
May 30, 2038compositionUS 11612593
May 30, 2038compositionUS 11612594
May 30, 2038compositionUS 11633387
May 30, 2038method-of-use (U-2371)US 11666564
May 30, 2038compositionUS 11786516
May 30, 2038method-of-use (U-2371)US 11813255
May 30, 2038compositionUS 12042488
May 30, 2038compositionUS 12042489
May 30, 2038method-of-use (U-2371)US 12042490
May 30, 2038compositionUS 12109205
May 30, 2038compositionUS 12280042
Mar 15, 2037method-of-use (U-2371)US 10076514
Mar 15, 2037method-of-use (U-2371)US 11234972
Oct 20, 2031method-of-use (U-2371)US RE48608
Feb 12, 2029method-of-use (U-2371)US 108139212.6y
Feb 12, 2029method-of-use (U-2371)US 90955842.6y
Apr 28, 2028method-of-use (U-2371)US 105250451.8y
Apr 28, 2028method-of-use (U-2371)US 109258661.8y
Apr 28, 2028method-of-use (U-2371)US 110335381.8y
Apr 28, 2028method-of-use (U-2372)US 99996181.8y
May 16, 2027method-of-use (U-2371)US 10383864313d
May 16, 2027method-of-use (U-2371)US 10406143313d
May 16, 2027method-of-use (U-2371)US 11241422313d
May 16, 2027method-of-use (U-2371)US 9000011313d
May 16, 2027method-of-use (U-2371)US 9480682313d
May 16, 2027method-of-use (U-2371)US 9987263313d

migalastat hydrochloride

all catalysts(0)

News(0)

Report a data issue

Patent cliff

patents (62)

comments(0)